Economic impact of abrocitinib monotherapy and combination therapy in patients with moderate-to-severe atopic dermatitis: Results from JADE MONO-2 and JADE COMPARE
Titel:
Economic impact of abrocitinib monotherapy and combination therapy in patients with moderate-to-severe atopic dermatitis: Results from JADE MONO-2 and JADE COMPARE
Auteur:
Gooderham, Melinda J. Chu, Chia-Yu Rojo, Ricardo Valdez, Hernan Biswas, Pinaki Cameron, Michael C. Feeney, Claire Encinas, Gerardo A. Peeples-Lamirande, Kathleen Cappelleri, Joseph C. Myers, Daniela E. DiBonaventura, Marco